Different gene expression patterns in invasive lobular and ductal carcinomas of the breast

Molecular Biology of the Cell

Volumn 15, Issue 6, 2004, Pages 2523-2536

  Zhao, Hongjuan ^a   Langerød, Anita ^b   Ji, Youngran ^a   Nowels, Kent W ^a   Nesland, Jahn M ^b   Tibshirani, Rob ^a   Bukholm, Ida K ^c   Kåresen, Rolf ^d   Botstein, David ^a,e   Børresen Dale, Anne Lise ^b   Jeffrey, Stefanie S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ALGORITHM; ARTICLE; BREAST CARCINOMA; BREAST INVASIVE DUCTAL CARCINOMA; BREAST INVASIVE LOBULAR CARCINOMA; CANCER INVASION; CELL ADHESION; CELL GROWTH; CELL MOTILITY; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; ELECTRON TRANSPORT; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNITY; LIPID METABOLISM; LIPID TRANSPORT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA;

EID: 2542454682     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-11-0786     Document Type: Article

References (65)

1. Agarwal, V.R., Bischoff, E.D., Hermann, T., and Lamph, W.W. (2000). Induction of adipocyte specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin). Cancer Res. 60, 6033-6038.
2. Ahr, A., Holtrich, U., Solbach, C., Scharl, A., Strebhardt, K., Karn, T., and Kaufmann, M. (2001). Molecular classification of breast cancer patients by gene expression profiling. J. Pathol. 195, 312-320.
3. Ahr, A., Karn, T., Solbach, C., Seiter, T., Strebhardt, K., Holtrich, U., and Kaufmann, M. (2002). Identification of high risk breast-cancer patients by gene expression profiling. Lancet 359, 131-132.
4. Ashburner, et al. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29.
5. Bartsch, H., Nair, J., and Owen, R.W. (1999). Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 20, 2209-2218.
6. Bedner, E., Harezga, B., Osborn, M., and Domagala, W. (1995). Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study. Pol. J. Pathol. 46, 11-15.
7. Berx, G., Cleton-Jansen, A.M., Strumane, K., de Leeuw, W.J., Nollet, F., van Roy, F., and Cornelisse, C. (1996). E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13, 1919-1925.
8. Borst, M.J., and Ingold, J.A. (1993). Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114, 637-641; discussion 641-632.
9. Buerger, H., Simon, R., Schafer, K.L., Diallo, R., Littmann, R., Poremba, C., van Diest, P.J., Dockhom-Dworniczak, B., and Bocker, W. (2000). Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol. Pathol. 53, 118-121.
10. Bukholm, I.K., Nesland, J.M., Karesen, R., Jacobsen, U., and Borresen, A.L. (1997). Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J. Pathol. 181, 140-145.
11. Bumpers, H.L., Hassett, J.M., Jr., Penetrante, R.B., Hoover, E.L., and Holyoke, E.D. (1993). Endocrine organ metastases in subjects with lobular carcinoma of the breast. Arch. Surg. 128, 1344-1347.
12. Chen, X., et al. (2003). Variation in gene expression patterns in human gastric cancers. Mol. Biol. Cell 14, 3208-3215.
13. Cleton-Jansen, A.M. (2002). E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res. 4, 5-8.
14. Coradini, D., Pellizzaro, C., Veneroni, S., Ventura, L., and Daidone, M.G. (2002). Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence. Br. J. Cancer 87, 1105-1111.
15. Daling, J.R., et al. (2002). Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer 95, 2455-2464.
16. Dixon, A.R., Ellis, I.O., Elston, C.W., and Blamey, R.W. (1991). A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast. Br. J. Cancer 63, 634-635.
17. Domagala, W., Wozniak, L., Lasota, J., Weber, K., and Osborn, M. (1990). Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am. J. Pathol. 137, 1059-1064.
18. Eisen, M.B., Spellman, P.T., Brown, P.O., and Botstein, D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868.
19. Elston, E.W., and Ellis, I.O. (1993). Method for grading breast cancer. J. Clin. Pathol. 46, 189-190.
20. Flagiello, D., Gerbault-Seureau, M., Sastre-Garau, X., Padoy, E., Vielh, P., and Dutrillaux, B. (1998). Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer. Genes Chromosomes Cancer 23, 300-306.
21. Geradts, J., and Ingram, C.D. (2000). Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast. Mod. Pathol. 13, 945-953.
22. Gollub, J., et al. (2003). The Stanford Microarray Database: data access and quality assessment tools. Nucleic Acids Res. 31, 94-96.
23. Gunther, K., Merkelbach-Bruse, S., Amo-Takyi, B.K., Handt, S., Schroder, W., and Tietze, L. (2001). Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization. J. Pathol. 193, 40-47.
24. Gupta, A., Deshpande, C.G., and Badve, S. (2003). Role of E-cadherins in development of lymphatic tumor emboli. Cancer 97, 2341-2347.
25. Harris, J.R., Lippman, M.E., Morrow, M., and Osborne, C.K., Eds. (2000). Diseases of the Breast 2nd Ed., Philadelphia: Lippincott Willams & Wilkins.
26. Hunt, N.C., Douglas-Jones, A.G., Jasani, B., Morgan, J.M., and Pignatelli, M. (1997). Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch. 430, 285-289.
27. Lee, A.H., Dublin, E.A., Bobrow, L.G., and Poulsom, R. (1998). Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J. Pathol. 185, 394-401.
28. Lehr, H.A., Folpe, A., Yaziji, H., Kommoss, F., and Gown, A.M. (2000). Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma. Am. J. Clin. Pathol. 114, 190-196.
29. Li, C.I., Anderson, B.O., Porter, P., Holt, S.K., Daling, J.R., and Moe, R.E. (2000a). Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer 88, 2561-2569.
30. Li, C.I., Weiss, N.S., Stanford, J.L., and Daling, J.R. (2000b). Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88, 2570-2577.
31. Li, C.I., Anderson, B.O., Daling, J.R., and Moe, R.E. (2003). Trends in incidence rates of invasive lobular and ductal breast carcinoma. J. Am. Med. Assoc. 289, 1421-1424.
32. Lossos, I.S., Alizadeh, A.A., Diehn, M., Warnke, R., Thorstenson, Y., Oefner, P.J., Brown, P.O., Botstein, D., and Levy, R. (2002). Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc. Natl. Acad. Sci. USA 99, 8886-8891.
33. Nagae, Y., Kameyama, K., Yokoyama, M., Naito, Z., Yamada, N., Maeda, S., Asano, G., Sugisaki, Y., and Tanaka, S. (2002). Expression of E-cadherin catenin and C-erbB-2 gene products in invasive ductal-type breast carcinomas. J. Nippon Med. Sch. 69, 165-171.
34. Natarajan, R., and Nadler, J. (1998). Role of lipoxygenases in breast cancer. Front. Biosci. 3, E81-E88.
35. Newstead, G.M., Baute, P.B., and Toth, H.K. (1992). Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology 184, 623-627.
36. Pandis, N., et al. (1996). Correlation between karyotypic pattern and clincopathologic features in 125 breast cancer cases. Int. J. Cancer 66, 191-196.
37. Perou, C.M., et al. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
38. Pollack, J.R., Sorlie, T., Perou, C.M., Rees, C.A., Jeffrey, S.S., Lonning, P.E., Tibshirani, R., Botstein, D., Borresen-Dale, A.L., and Brown, P.O. (2002). Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. USA 99, 12963-12968.
39. Rahimi, N., Tremblay, E., McAdam, I., Roberts, A., and Elliott, B. (1998). Autocrine secretion of TGF-beta 1 and TGF-beta 2 by pre-adipocytes and adipocytes: a potent negative regulator of adipocyte differentiation and proliferation of mammary carcinoma cells. In Vitro Cell Dev. Biol. Anim. 34, 412-420.
40. Rey, M.J., et al., (1998). p21 WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. J. Pathol. 184, 265-271.
41. Rose, D.P., Connolly, J.M., and Liu, X.H. (1997). Fatty acid regulation of breast cancer cell growth and invasion. Adv. Exp. Med. Biol. 422, 47-55.
42. Rosenthal, S.I., Depowski, P.L., Sheehan, C.E., and Ross, J.S. (2002). Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer. Appl. Immunohistochem. Mol. Morphol. 10, 40-46.
43. Russo, J., Gusterson, B.A., Rogers, A.E., Russo, I.H., Wellings, S.R., and van Zwieten, M.J. (1990). Comparative study of human and rat mammary tumorigenesis. Lab. Investig. 62, 244-278.
44. Russo, J., Hu, Y.F., Silva, I.D., and Russo, I.H. (2001). Cancer risk related to mammary gland structure and development. Microsc. Res. Tech. 52, 204-223.
45. Russo, J., and Russo, I.H. (1994). Toward a physiological approach to breast cancer prevention. Cancer Epidemiol. Biomarkers Prev. 3, 353-364.
46. Sastre-Garau, X., Jouve, M., Asselain, B., Vincent-Salomon, A., Beuzeboc, P., Dorval, T., Durand, J.C., Fourquet, A., and Pouillart, P. (1996). Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 77, 113-120.
47. Serre, C.M., Clezardin, P., Frappart, L., Boivin, G., and Delmas, P.D. (1995). Distribution of thrombospondin and integrin alpha V in DCIS, invasive ductal and lobular human breast carcinomas. Analysis by electron microscopy. Virchows Arch. 427, 365-372.
48. Sherlock, G., et al. (2001). The Stanford Microarray Database. Nucleic Acids Res. 29, 152-155.
49. Siitonen, S.M., Kononen, J.T., Helin, H.J., Rantala, I.S., Holli, K.A., and Isola, J.J. (1996). Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol. 105, 394-402.
50. Sorlie, T., et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869-10874.
51. Sorlie, T., et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 100, 8418-8423.
52. Soslow, R.A., Carlson, D.L., Horenstein, M.G., and Osborne, M.P. (2000). A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas. Breast Cancer Res. Treat. 61, 161-170.
53. Stoll, B.A. (1998). Breast cancer and the western diet: role of fatty acids and antioxidant vitamins. Eur. J. Cancer 34, 1852-1856.
54. Tibshirani, R., Hastie, T., Narasimhan, B., and Chu, G. (2002). Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA 99, 6567-6572.
55. Toikkanen, S., Pylkkanen, L., and Joensuu, H. (1997). Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br. J. Cancer 76, 1234-1240.
56. Tusher, V.G., Tibshirani, R., and Chu, G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121.
57. van't Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A., Bernards, R., and Friend, S.H. (2002). Expression profiling predicts outcome in breast cancer. Breast Cancer Res. 5, 57-58.
58. van de Vijver, et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009.
59. Verkooijen, H.M., Fioretta, G., Vlastos, G., Morabia, A., Schubert, H., Sappino, A.P., Pelte, M.F., Schafer, P., Kurtz, J., and Bouchardy, C. (2003). Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int. J. Cancer 104, 778-781.
60. Wellings, S.R. (1980). Development of human breast cancer. Adv. Cancer Res. 31, 287-314.
61. Wellings, S.R., Jensen, H.M., and Marcum, R.G. (1975). An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 55, 231-273.
62. West, M., Blanchette, C., Dressman, H., Huang, E., Ishida, S., Spang, R., Zuzan, H., Olson, J.A., Jr., Marks, J.R., and Nevins, J.R. (2001). Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci USA 98, 11462-11467.
63. Winchester, D.J., Chang, H.R., Graves, T.A., Menck, H.R., Bland, K.I., and Winchester, D.P. (1998). A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J. Am. Coll. Surg. 186, 416-422.
64. Yeatman, T.J., Cantor, A.B., Smith, T.J., Smith, S.K., Reintgen, D.S., Miller, M.S., Ku, N.N., Baekey, P.A., and Cox, C.E. (1995). Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann. Surg. 222, 549-559; discussion 559-561.
65. Zhao, H., Hastie, T., Whitfield, M.L., Borresen-Dale, A.L., and Jeffrey, S.S. (2002). Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis. BMC Genomics 3, 31.